Importance of specific IgM antibodies in 116 patients with various stages of syphilis.
AUTOR(ES)
Merlin, S
RESUMO
We tested 222 serum samples obtained from 51 patients presenting with syphilis, before and after treatment; 117 from 65 patients with a history of syphilis (114) or yaws (3); 77 from 71 patients with no evidence of syphilis; and 1117 serologically negative serum samples. Our tests included the IgM fluorescent treponemal antibody absorbed (IgM-FTA-ABS) and solid phase haemadsorption assay (SPHA) techniques. According to the stage of development of syphilis, IgM antibodies were found in 83-100% of the serum samples. This permitted a precise diagnosis to be made and cure assessed. As IgM antibodies were absent in serum from patients with healed syphilis, resolved syphilis could be distinguished from developing syphilis. The sensitivity (92%) of the IgM-FTA-ABS test was comparable with that of the SPHA (96%), but the SPHA was more specific (97.4%) than the IgM-FTA-ABS test (89.61%).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1011772Documentos Relacionados
- An IgM capture enzyme linked immunosorbent assay to detect IgM antibodies to treponemes in patients with syphilis.
- Microenzyme-linked immunosorbent assay for the detection of specific IgM antibodies in human syphilis.
- Investigation of a specific IgM antibody test in neonatal congenital syphilis.
- Treponema pallidum specific IgM haemagglutination test for serodiagnosis of syphilis.
- IgM class antitreponemal antibody in treated and untreated syphilis.
